Business

July 29, 2014

Oxygen Bio reports wider net loss in fiscal 2014

Oxygen Biotherapeutics reported wider net loss in 2014 as the Morrisville company in part because of costs related to its licensing of its cardiovascular drug in October.

Related content

Comments

Videos

Editor's Choice Videos